Skip to main content
. 2015 Aug 25;2(2):127–139. doi: 10.1007/s40744-015-0015-x

Fig. 4.

Fig. 4

Adjusted hazard ratios for discontinuation of index anti-TNF medication at varying levels of nbDMARD adherence during anti-TNF treatment period. Anti-TNF anti-tumor necrosis factor, CI confidence interval, nbDMARD non-biologic anti-rheumatic disease-modifying drug